Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIMERVAX LP.8.1 in Older Adults
2025-524021-41-00Phase 4Completed
- Sponsor
- HIPRA
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of PHH-1V in coronavirus disease 2019 (COVID-19), sponsored by HIPRA. Primary endpoints: Solicited local and systemic reactions through Day 7, Unsolicited adverse events through end of study and 5 more. Started Oct 2025; status: completed.
02
Drugs
PHH-1V
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2025-524021-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524021-41-00.